MedtronicXSWX:MDT +1.21%21 PE Ratio (TTM) is 22.06 as of Jun. 25, 2026, which is 23% below its 10-year median of 28.59. GuruFocus rates XSWX:MDT with a GF Score™ of 21/100 and a GF Value™ of CHF80.97 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 437 Medical Devices & Instruments companies, Medtronic ranks better than 59.27% on this metric.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-06-25), Medtronic's share price is
CHF65.29.
Medtronic's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 was CHF2.96. Therefore, Medtronic's PE Ratio (TTM) for today is 22.06.
Good Sign:
Medtronic PLC stock PE Ratio (=21.48) is close to 10-year low of 19.66.
The historical rank and industry rank for Medtronic's PE Ratio (TTM) or its related term are showing as below:
XSWX:MDT'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: 19.66 Med: 28.59 Max: 61.31
Current: 21.48
During the past 13 years, the highest PE Ratio (TTM) of Medtronic was 61.31. The lowest was 19.66. And the median was 28.59.
XSWX:MDT's PE Ratio (TTM) is ranked better than 59.27% of 437
companies
in the Medical Devices & Instruments industry
Industry Median: 25.95
vs XSWX:MDT: 21.48
As of today (2026-06-25), Medtronic's share price is CHF65.29.
Medtronic's EPS without NRI for the trailing twelve months (TTM) ended in Apr. 2026 was CHF4.39. Therefore, Medtronic's PE Ratio without NRI for today is 14.88.
During the past 13 years, Medtronic's highestPE Ratio without NRI was 37.38. The lowest was 12.93. And the median was 17.70.
Medtronic's EPS without NRI for the
three
months ended in Apr. 2026 was CHF1.22.
Its EPS without NRI for the trailing twelve months (TTM) ended in Apr. 2026 was CHF4.39.
During the past 12 months, Medtronic's average EPS without NRIGrowth Rate was 0.70% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 1.50% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 3.00% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 2.20% per year.
During the past 13 years, Medtronic's highest 3-Year average EPS without NRI Growth Rate was 28.90% per year. The lowest was -2.40% per year. And the median was 11.40% per year.
Medtronic's EPS (Basic) for the
three
months ended in Apr. 2026 was CHF0.76.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Apr. 2026 was CHF2.97.
Medtronic (XSWX:MDT) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
Medtronic PE Ratio (TTM) Related Terms
Medtronic PE Ratio (TTM) Historical Data
* Premium members only.
The historical data trend for Medtronic's PE Ratio (TTM) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:MDT vs SYK, BSX, EW: PE Ratio (TTM) Comparison
For the Medical Devices subindustry, Medtronic's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medtronic PE Ratio (TTM) vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where Medtronic's PE Ratio (TTM) falls into.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
Medtronic's PE Ratio (TTM) for today is calculated as
Medtronic's Share Price of today is CHF65.29.
Medtronic's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF2.96.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Medtronic (XSWX:MDT) has a PE Ratio (TTM) of 22.06 as of Jun. 25, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Medtronic and its competitors. This is 23% below median its historical median of 28.59. Over the past decade, Medtronic's PE Ratio (TTM) has ranged from 19.66 to 61.31. According to the industry distribution chart, Medtronic ranks #178 out of 437 companies in the Medical Devices & Instruments industry, placing it in the top 40.7%.
Is Medtronic's PE Ratio (TTM) too high?
Medtronic's current PE Ratio (TTM) of 22.06 is 23% below median its 10-year median of 28.59. Over the past 10 years, this metric has ranged from a low of 19.66 to a high of 61.31. The Medical Devices & Instruments industry median PE Ratio (TTM) is 25.95. Medtronic's value of 22.06 is 15% below this industry median. Based on the distribution chart, Medtronic ranks #178 out of 437 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medtronic has a GF Score™ of 21/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's PE Ratio (TTM) compare to SYK and BSX?
According to the Medical Devices & Instruments industry distribution chart, Medtronic ranks #178 out of 437 companies for PE Ratio (TTM). This puts Medtronic in the upper half of its industry. The industry median PE Ratio (TTM) is 25.95. Medtronic's value of 22.06 is 15% below this benchmark. Historically, Medtronic's own PE Ratio (TTM) has ranged from 19.66 to 61.31 over the past decade. While the company's 10-year median is 28.59 vs. the industry median of 25.95, Medtronic has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Medical Devices & Instruments company?
The median PE Ratio (TTM) among Medical Devices & Instruments companies is 25.95, based on 437 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medtronic's current PE Ratio (TTM) of 22.06 is 15% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Medtronic and its competitors. For the Medical Devices & Instruments industry, the median PE Ratio (TTM) is 25.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medtronic's current PE Ratio (TTM) is 22.06, which is 23% below median its own 10-year median of 28.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (XSWX:MDT) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF80.97, compared to a current price of CHF65.29 — trading 19.4% below its estimated fair value. The current PE Ratio (TTM) is 22.06, which is 23% below median its 10-year median of 28.59 and 15% below the Medical Devices & Instruments industry median of 25.95. Medtronic's overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Medtronic (XSWX:MDT), the current PE Ratio (TTM) is 22.06 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medtronic (XSWX:MDT) Overvalued in 2026?
Based on GuruFocus' analysis, Medtronic stock appears to be undervalued.
The current stock price of CHF65.29 is trading 19.4% below its estimated GF Value™ of CHF80.97.
GuruFocus considers Medtronic to be Modestly Undervalued.
Key valuation signals for XSWX:MDT:
PE Ratio (TTM): 22.06 (23% below median its 10-year median of 28.59)
GF Value™: CHF80.97 vs. price of CHF65.29 (19.4% below fair value)
Industry Position: 15% below the Medical Devices & Instruments median (#178 of 437)
No single metric tells the full story. See the XSWX:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
21GF Score
Get the complete analysis for XSWX:MDT
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MDT has been successfully added to your 
